Research and experimental development on natural sciences and engineering
BIOSYNTECH SURNADAL AS
Revenue 2025
NOK 0
Operating profit
NOK −24,000
Equity
NOK 992,000
Incorporated
2023
Share capital
NOK 1.0m
Roles
Regnskapsfører
Styrets lederØystein Selen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SOLUSINET AS | 49.5% | 510000.000000 | 2025 |
| TOM KRISTIAN HOFFMANN | 19.4% | 200000.000000 | 2025 |
| MEDCIS AS | 19.4% | 200000.000000 | 2025 |
| UTMARKSBEITE AS | 3.9% | 40000.000000 | 2025 |
| PROMØRE AS | 3.9% | 40000.000000 | 2025 |
| FLAVIRAMULUS HOLDING AS | 3.9% | 40000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.